Leading the Charge

We’ve built a company poised to produce transformative pharmaceutical solutions by bringing together leaders steeped in all the functions needed to bring new drugs to life. With a deeply skilled management team directing our day-to-day wins, and a Board with a stellar track record, we’re ready to take on the world’s diseases, ailments and adversity.

The Backbone of our Innovation

The Dova Board brings impressive experience to the table, bright minds from across the spectrum of relevant disciplines helping to illuminate the path forward for our pharmaceutical solutions.

Alfred J. Novak

Joined Dova Board: May 2017

Mr. Novak has served on, and is currently serving on, a number of boards including LivaNova, OrbusNeich, Medical Technology Company, Ltd., ProRhythm, Inc., Sutura, Inc., and Biosense, Inc. From April 2014 until March 2015, Mr. Novak served as President and Chief Executive Officer of Syntheon Cardiology, LLC, an early-stage company developing a percutaneous prosthetic aortic heart valve. In 1998, he was a founder of Syntheon, LLC, a privately held company that focused on minimally invasive medical devices for the gastroenterology and vascular markets. Mr. Novak currently serves on the board of directors of Restoring Heroes Foundation, an organization devoted to assisting veterans with obtaining access to new and progressive therapies. Mr. Novak received his B.S. in Marine Transportation from the United States Merchant Marine Academy and his M.B.A. from the Wharton School, University of Pennsylvania.